Detalles de la búsqueda
1.
Expanded access to anticancer treatments from conversion to biosimilar pegfilgrastim-cbqv in US breast cancer patients.
Future Oncol
; 18(3): 363-373, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34747185
2.
(Un)standardized testing: the diagnostic odyssey of children with rare genetic disorders in Alberta, Canada.
Genet Med
; 23(2): 272-279, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989270
3.
Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer.
Future Oncol
; 17(33): 4561-4570, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382416
4.
Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis.
Support Care Cancer
; 28(3): 1031-1039, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823054
5.
Correction: The value of diagnostic testing for parents of children with rare genetic diseases.
Genet Med
; 21(11): 2662, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31316168
6.
Direct health-care costs for children diagnosed with genetic diseases are significantly higher than for children with other chronic diseases.
Genet Med
; 21(5): 1049-1057, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30245512
7.
The value of diagnostic testing for parents of children with rare genetic diseases.
Genet Med
; 21(12): 2798-2806, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31239560
8.
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study.
Future Oncol
; 15(8): 897-907, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30827127
9.
Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study.
Support Care Cancer
; 27(6): 2301-2312, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30343410
10.
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study.
BMC Nephrol
; 20(1): 81, 2019 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30836953
11.
An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trial.
BMC Musculoskelet Disord
; 20(1): 89, 2019 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30797238
12.
CM-SHARE: Development, Integration, and Adoption of an Electronic Health Record-Linked Digital Health Solution to Support Care for Diabetes in Primary Care.
Clin Diabetes
; 37(4): 338-346, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31660006
13.
Corrigendum: What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Genet Med
; 20(1): 165, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29261179
14.
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 studyâ©.
Clin Nephrol
; 89 (2018)(1): 1-9, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29168688
15.
Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine.
Value Health
; 20(1): 32-39, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212966
16.
Expanded access to cancer treatments from conversion to neutropenia prophylaxis with biosimilar filgrastim-sndz.
Future Oncol
; 13(25): 2285-2295, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870106
17.
Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study.
Support Care Cancer
; 25(6): 1819-1828, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28111718
18.
What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Genet Med
; 18(12): 1295-1302, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27253734
19.
Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).
Support Care Cancer
; 24(2): 911-925, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26306517
20.
Assessment of Reproducibility of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Bacterial and Yeast Identification.
J Clin Microbiol
; 53(7): 2349-52, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926486